Thread by @dablmed

I want to introduce a long-term play on my list of potential #Multibaggers that is just getting started, $SENS (@senseonics)

A medical technology company that disrupts the CGM system market for diabetics

Below is an intro from my in-depth research based on my original framework

$SENS Investment Thesis (1/7)

– Diabetes is one of the most common diseases (~500 million people worldwide have one of the types of diabetes)
– Unfortunately, the number of people with diabetes is continuously growing (9.3% of the global population in 2019 to 11% by 2045)

$SENS Investment Thesis (2/7)

– Diabetics are required to monitor their blood glucose levels constantly, and traditionally it is done by finger pricking
– Many companies tried to solve this problem in a different, more convenient way

$SENS Investment Thesis (3/7)

– As a result, a CGM (continuous glucose monitor) system was introduced back in 1999 and steadily evolved since then
– Today, CGMs does not require pricking the finger
– Current most popular CGM systems are from the market leaders $DXCM and $ABT

$SENS Investment Thesis (4/7)

– However, CGMs from these companies have some limitations and the major one is wearing time
– Essentially, you must buy a new CGM pack of sensors every 10 days (for Dexcom G6) and 14 days (for FreeStyle Libre)

$SENS Investment Thesis (5/7)

– Senseonics came up with their groundbreaking solution in 2018: Eversense CGM system
– This is the first FDA-approved CGM with a fully implantable sensor that can be worn for up to 90 days

$SENS Investment Thesis (6/7)

– But it also had limitations (must be calibrated several times per day)
– Currently, the company is awaiting an FDA approval of a 180-day CGM system (expected in Q4 2021) that will need once a day calibration

$SENS Investment Thesis (7/7)

– A true game-changer is in the Sensionics pipeline – a 365-day sensor that will need once a week calibration

$SENS The opportunity

I believe with that level of innovation, pretty strong management, and the new partnership with Ascensia (upon which they take all S&M costs), Senseonics is a true long-term winner in this space and potentially not even a 10-bagger, but a 100-bagger.

Full highlights from my in-depth research of $SENS include:

– Company Overview
– Technology
– Total Addressable Market
– MOAT
– Business Model
– Team
– Ownership
– Financials
– Valuation + PT
– Risks
– Optionality

$SENS highlights (an example)

Here is an example of the highlights from my in-depth research of $BFLY

Full $SENS highlights will be available soon on my platform that is launching this month.

You can register now via Substack – 10baggerdan.substack.com (you will receive a link to join once the platform is live).

I am also working on an eBook called «Finding Multibaggers On Stock Market 101», where I share my knowledge and experience finding multibaggers like $SHOP, $ETSY, $TDOC, and explain why a company like $SENS is the next potential #multibagger.

Join via Substack (link in bio).